New Drug from UTSW Could Offer Prostate Cancer Treatment

New Drug from UTSW Could Offer Prostate Cancer Treatment
D Healthcare Daily
Raj hopes the drug that has been tested in mouse and human tissue will lead to new treatment options and increased longevity for men diagnosed with prostate cancer. Additional testing is needed before the drug can be studied in Phase 1 clinical trials ...
 
http://healthcare.dmagazine.com/2013/05/29/new-drug-from-utsw-offers-possible-prostate-cancer-treatment/

GSK Hits Trifecta with Melanoma Drug, Dx Approvals

GSK Hits Trifecta with Melanoma Drug, Dx Approvals
Genetic Engineering News
A total 250 previously untreated adult patients with BRAF V600E mutation-positive unresectable or metastatic melanoma were randomized to either drug. Mekinist was approved after Phase III data showed a statistically significant increase in PFS, to a ...

http://www.genengnews.com/gen-news-highlights/gsk-hits-trifecta-with-melanoma-drug-dx-approvals/81248422/

Who pays for drugs used in Phase 1 clinical trials? Clues to Cancer

Who pays for drugs used in Phase 1 clinical trials Clues to Cancer ...

When a drug is Food and Drug Administration-approved but being used to treat a cancer other than what it was originally intended for, insurance often ...

http://www.cleveland.com/healthfit/index.ssf/2013/04/who_pays_for_drugs_used_in_pha.html

PHARMA IQ-A Global Guide to Formulation and Drug Delivery

A Global Guide to Formulation and Drug Delivery
Hear from leading experts
http://www.pharma-iq.com/pre-clinical-discovery-and-development/white-papers/a-global-guide-to-formulation-and-drug-delivery/?mac=PMIQ_SIB

PHARMA IQ-Global Insights on Pharmaceutical Contract Manufacturing

Global Insights on Pharmaceutical Contract Manufacturing
Download report now
http://www.pharma-iq.com/manufacturing/white-papers/pharmaceutical-contract-manufacturing-2012-2014/?mac=PMIQ_SIB

PHARMA IQ-Five Strategies to Accelerate the Transformation of the Pharmaceutical Industry by 2020

Future Pharma

Five Strategies to Accelerate the Transformation of the Pharmaceutical Industry by 2020

DOWNLOAD HERE
http://www.pharma-iq.com/market-access/white-papers/future-pharma-five-strategies-to-accelerate-the-tr/?mac=PMIQ_SIB

Great News For Gilead Sciences And HCV Patients

Great News For Gilead Sciences And HCV PatientsSeeking AlphaGilead submitted a New Drug Application [NDA] with the same Phase 3 trial data to the FDA in April 2013. The FDA has since issued a Form 483 letter questioning the company's test procedures, stability testing and laboratory controls regarding several ...http://seekingalpha.com/article/1465861-great-news-for-gilead-sciences-and-hcv-patients?source=google_news